↓ Skip to main content

N-Acetylcysteine to Combat COVID-19: An Evidence Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 1,342)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
7 news outlets
blogs
2 blogs
twitter
2673 X users
patent
4 patents
facebook
5 Facebook pages
reddit
2 Redditors
video
12 YouTube creators

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
290 Mendeley
Title
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Published in
Therapeutics and Clinical Risk Management, November 2020
DOI 10.2147/tcrm.s273700
Pubmed ID
Authors

Zhongcheng Shi, Carlos A Puyo

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 2,673 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 290 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 290 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 47 16%
Researcher 31 11%
Student > Master 22 8%
Other 20 7%
Student > Doctoral Student 15 5%
Other 37 13%
Unknown 118 41%
Readers by discipline Count As %
Medicine and Dentistry 52 18%
Nursing and Health Professions 28 10%
Pharmacology, Toxicology and Pharmaceutical Science 25 9%
Biochemistry, Genetics and Molecular Biology 17 6%
Agricultural and Biological Sciences 13 4%
Other 24 8%
Unknown 131 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2019. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2024.
All research outputs
#4,884
of 26,785,907 outputs
Outputs from Therapeutics and Clinical Risk Management
#1
of 1,342 outputs
Outputs of similar age
#234
of 447,025 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 18 outputs
Altmetric has tracked 26,785,907 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,342 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,025 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.